Pharma major, Lupin Limited, today announced that the company has launched Atorvastatin Calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg after receiving approval from United States Food & Drug Administration (USFDA). The product will be manufactured at the company's Nagpur facility in India.